Name | Lovastatin sodium salt |
---|---|
Synonyms |
MB 530B
sodium mevinolinate lovastatin acid sodium salt lovastatinic sodium salt pravastatin lovastatin hydroxy acid sodium salt Sodium (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthalenyl]-3,5-dihydroxyheptanoate sodium (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate [1S-[1a(bS,dS),2a,6b,8b(R),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic acid monosodium salt 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt, (βR,δR,1S,2S,6R,8S,8aR)- (1:1) lovastatin Na Lovastatin Hydroxy Acid LOVASTATIN SODIUM mevinolin sodium salt Lovastatin Impurity 2 |
Description | Lovastatin hydroxy acid sodium (Mevinolinic acid sodium) is a highly potent inhibitor of HMG-CoA reductase with a Ki of 0.6 nM[1]. |
---|---|
Related Catalog | |
Target |
Ki: 0.6 nM (HMG-CoA reductase)[1] |
In Vitro | Mevinolin in the hydroxy-acid form, mevinolinic acid, is a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase [mevalonate: NADP+ oxidoreductase (CoA-acylating)][1]. |
References |
Boiling Point | 602.3ºC at 760 mmHg |
---|---|
Melting Point | 154-160ºC |
Molecular Formula | C24H37NaO6 |
Molecular Weight | 444.537 |
Flash Point | 199.1ºC |
Exact Mass | 444.248779 |
PSA | 106.89000 |
LogP | 2.38090 |
Hazard Codes | Xi |
---|
~% 75225-50-2 |
Literature: US2005/85528 A1, ; Page/Page column 4 ; US 20050085528 A1 |
Precursor 1 | |
---|---|
DownStream 0 |